Chicago has always been a hotbed for technological innovation and now the Windy City is getting involved with the medical field through a rising start-up known as Tempus. Tempus was co-founded by Eric Lefkofsky in 2015 with the goal of helping to revolutionize the way that customers and medical health professionals interact with and access important medical data. The company is now valued at north of $1 billion and this has allowed Tempus to earn the coveted Unicorn Status.
The goal of Tempus is to utilize data in a way that helps to streamline and maximize the effectiveness of cancer care in the modern medical world. Having seen how the system works up close, through a personal relationship, Lefkofsky came to the realization that there is a ton of room for improvement within the field. So, Tempus compiles data from multiple sources before porting it into an accessible database. This database is then utilized by patients, family members and healthcare professionals in order to track cancer care approaches and see which ones are most effective.
We are currently living in the data-driven age of technology and Lefkofsky’s approach as the co-founder of Tempus is serving as a unique opportunity to help change lives through data. Leaning on clinical data and molecular data, Tempus is quickly becoming vital in the search for trends among cancer care patients. Tempus relies not only on old data but it also ports data from patients that are currently undergoing treatment. The data collection system is advanced enough that it can utilize digital database and simple enough that it can be used to port in handwritten doctor notes into a searchable platform.
Right now, Tempus employs nearly 400 workers and their business forecast shows that the company will be adding nearly 30 new employees every single month from here on out. With success in their approach, Tempus has quickly captured the eye of several major investors. It was recently announced that Tempus had earned an additional $80 million in investments which pushes their 3-year-total to just north of $210 million. With this kind of early success, the sky appears to be the limit for Tempus.
For decades, scientists and medical professionals have known that there is a positive link between the consumption of wine and an overall decrease in cardiovascular disease. So strong is this relationship that people who regularly drink wine in moderation may have increased life expectancies of up to 5 years longer than those who do not.
Yet, despite this strong and highly compelling evidence of beneficial effects, the major medical bodies still do not recommend that those who do not currently drink wine begin doing so. While this may seem like a surprising contradiction, it stems from the dangers of alcohol consumption itself. Even though only 10 to 15 percent of all people who begin to drink alcohol will go on to develop an alcohol use disorder, the consequences of becoming an alcoholic are so severe that the benefits of wine consumption, even as notable as they are, get cancelled out at the population level by the risk of people developing alcohol use disorders.
Still, many researchers, companies and medical organizations have attempted to find a way to achieve the same benefits of moderate wine consumption without incurring any of the risks associated with the consumption of alcohol.
Now, Jeunesse Global, one of the most innovative health and beauty companies in the world, has devised a product that is able to confer all of the benefits of wine consumption and even more. Additionally, their solution contains no alcohol. Called Reserve, the drink contains resveratrol, one of the most potent health-protective ingredients in wine. Reserve also contains a number of so-called superfruits, including pomegranate, blueberry, acai, and concord grape. Together, these things make Reserve one of the most health-promoting and great-tasting health drinks on the market.
With so many antioxidants, Reserve packs the health-protecting punch of daily wine consumption with none of the risks. In addition to protecting against heart disease, Reserve also protects against diseases like peripheral artery disease, stroke and kidney dysfunction. It has been clinically shown to reduce the oxidative stress caused by free radicals. This makes Reserve a proven means to prevent against some of the worst ailments associated with aging.